| Literature DB >> 33994886 |
Shangrui Rao1, Zhonglin Wang1, Congtao Pan1, Yi Wang1, Zhe Lin1, Zhongliang Pan1, Jian Yu1.
Abstract
Purpose: The purpose of this study was to find the clinical significance and methods of using CN in endoscopic treatment for PTC. Materials andEntities:
Mesh:
Substances:
Year: 2021 PMID: 33994886 PMCID: PMC8096569 DOI: 10.1155/2021/6652315
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.161
Comparison of the general data among the two groups.
| Control group ( | CN injection group ( |
| |
|---|---|---|---|
| Sex | |||
| Male | 16 | 9 | 0.239 |
| Female | 42 | 41 | |
| Age (‾ | 44.0 ± 10.2 | 46.8 ± 11.9 | 0.199 |
| Tumor size (cm) | 0.63 ± 0.19 | 0.61 ± 0.24 | 0.720 |
| Average number of lymph nodes detected per case (number) | 4.72 ± 1.89 | 6.44 ± 2.08 | 0.000 |
Figure 1Black-stained lymph node, recurrent laryngeal nerve (RLN), and parathyroid gland under “negative imaging” seen during operation.
Figure 2Specimens of lymph nodes with black staining and microscopic findings in the experimental group (H&E ×100).
Figure 3Method A: injected by trocar.
Figure 4Method B: percutaneous puncture.
Figure 5Method C: improved percutaneous puncture.
Comparison of the parathyroid gland and RLN injury in two groups.
| Group | Number of cases | Detection of PGs case (%) | RLN injury case (%) |
|---|---|---|---|
| Control group | 58 | 16 (27.6%) | 4 (6.9%) |
| CN injection group | 50 | 6 (12%) | 3 (6%) |
|
| 0.045 | 1.0 |
Comparison of thyroid and parathyroid functions in two groups.
| Control group ( | CN injection group ( |
|
| |
|---|---|---|---|---|
| FT3 (pmol/L) | 4.40 ± 0.82 | 4.59 ± 0.77 | −1.26 | 0.208 |
| FT4 (pmol/L) | 12.58 ± 3.54 | 11.51 ± 2.60 | 1.76 | 0.08 |
| TSH (mIU/L) | 1.98 ± 1.63 | 2.01 ± 1.24 | −0.12 | 0.9 |
| PTH (ng/L) | 32.41 ± 16.46 | 33.70 ± 14.29 | −0.43 | 0.66 |
| Serum Ca2+ (mmol/L) | 2.15 ± 0.09 | 2.17 ± 0.09 | −0.82 | 0.41 |
FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyrotropin-stimulating hormone; PTH, parathyroid hormone; Serum Ca2+, serum calcium.